Abstract:Polymeric micelles after cross-linking can be overcome dissociation over dilution. In order to obtain cross-linked micelles, a novel pH-responsive copolymer, P(CL-ACL)-PDEAS, namely, poly(epsilon-caprolactone/aazidecaprolactone)-b-poly(N,N-diethylaminoethylmethacrylate)-r-poly(N-(3-sulfopropy1)-N-methacy-loxyethy-N, N-diethylammoniumbetaine) was synthesized with azide groups in the hydrophobic block. A cross-linker, 2,2'-bi(2"-acetylene ethyl formate) amide ethyl disulfide, was also synthesized. The synthesis process of P(CL-ACL)-PDEAS included a combination of ring-open polymerization of caprolactone monomers, replacement and transformation of end functional groups, atom transfer radical of DEA monomers and sulfonation of DEA groups. The successful synthesis of the copolymer and the cross-linker were confirmed by nuclear magnetic resonance, Fourier transform infraredand elemental analysis. P(CL-ACL)-PDEAS was used to form polymer micelles by self-assembly. The cross-linked micelles were obtained through "click" chemistry by adding the cross-linker and catalyst during the process of micelle formation. Laser particle size analyzer (DLS) and fluorescence spectrophotometer were used to characterize the properties of the micelles. As a result, the sizes of the uncross-linked micelles and cross-linked micelles were 97.34 and 121.8 nm, respectively, and unimodal size distribution was observed for both types of the micelles. However, after 1000 fold dilution, the size of the cross-linked micelles and their unimodal distribution remained, while the size of the uncross-linked micelles increased greatly and the size distribution became dual. This meant that the cross-linked micelles were more stable. In addition, acid-base titration test showed that both types of the micelles were pH-sensitive. Drug loading and release experiment were carried out using DOX as drug model. The drug loading content and the drug loading efficiency were similar for both types of the micelles. Finally, drug release experiment was executed in different conditions by simulating the human body's physiological environment. The results indicated that the cross-linked micelles released less DOX than the uncross-linked micelles under normal physiological conditions, whereas in the presence of DTT, the release rate of the cross-linked micelles was significantly accelerated, due to the disulfide bond breaking. Thus, as drug delivery carrier, the cross-linked micelles were able to release drug at specific site of tumor in response to the tumor microenvironment.

Bioreducible and Core‐crosslinked Hybrid Micelles from Trimethoxysilyl‐ended Poly(ε‐caprolactone)‐s‐s‐poly(ethylene Oxide) Block Copolymers: Thiol‐ene Click Synthesis and Properties

Core-shell-corona micelle stabilized by reversible cross-linkage for intracellular drug delivery.

Fabrication of Biocleavable Shell Cross-Linked Hybrid Micelles for Controlled Drug Release Using a Reducible Silica Monomer.

Balancing the Stability and Drug Release of Polymer Micelles by the Coordination of Dual-Sensitive Cleavable Bonds in Cross-Linked Core.

Reduction-responsive shell-crosslinked micelles prepared from Y-shaped amphiphilic block copolymers as a drug carrier

Fabrication of Core Crosslinked Polymeric Micelles as Nanocarriers for Doxorubicin Delivery: Self-Assembly, In Situ Diselenide Metathesis and Redox-Responsive Drug Release

Preparation and Characterization of Core-cross-linked pH-Responsive Micelles Containing Sulfobetaines

Redox-Sensitive Core Cross-Linked Polyethylene Glycol-Polypeptide Hybrid Micelles for Anticancer Drug Delivery

Ph‐responsive Core Crosslinked Polycarbonate Micelles Via Thiol‐acrylate Michael Addition Reaction

Functional Poly(Epsilon-Caprolactone)S Via Copolymerization Of Epsilon-Caprolactone And Pyridyl Disulfide-Containing Cyclic Carbonate: Controlled Synthesis And Facile Access To Reduction-Sensitive Biodegradable Graft Copolymer Micelles

Facile Construction of Dual-Bioresponsive Biodegradable Micelles with Superior Extracellular Stability and Activated Intracellular Drug Release.

Hydrazone Cross-Linked Micelles Based on Redox Degradable Block Copolymer for Enhanced Stability and Controlled Drug Release

Fabrication of Hybrid Micelles with Enhanced Permeability for Drug Delivery via a Diethoxymethylsilyl-Based Crosslinking Strategy

Facile Fabrication of Core Cross-Linked Micelles by RAFT Polymerization and Enzyme-Mediated Reaction.

Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.

Reduction-responsive Disassemblable Core-Cross-linked Micelles Based on Poly(ethylene Glycol)-B-poly(n-2-hydroxypropyl Methacrylamide)-Lipoic Acid Conjugates for Triggered Intracellular Anticancer Drug Release.

Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.

Facile Preparation of Core Cross-Linked Micelles from Catechol-Containing Amphiphilic Triblock Copolymer

Reduction-responsive core-shell-corona micelles based on triblock copolymers: novel synthetic strategy, characterization, and application as a tumor microenvironment-responsive drug delivery system.

Dithiolane-Crosslinked Poly(ε-caprolactone)-Based Micelles: Impact of Monomer Sequence, Nature of Monomer, and Reducing Agent on the Dynamic Crosslinking Properties.

C2JM30700F 11730..11738